SHEREEN ABOU-GHARBIA, PHARM.D, CMPP

Phone: 609-***-**** Email: acgfqu@r.postjobfree.com

Address: *** ********** *****, ******* *******, PA 19425

SUMMARY OF QUALIFICATIONS

Experienced and highly qualified pharmaceutical professional with over 9 years of experience in medical and

scientific affairs servicing as primary medical interface for stakeholders to provide information in support of

inline/emerging products across several therapeutic areas. Highly proficient in evaluating and interpreting

clinical data, articulately presenting complex scientific data to audiences, and leading cross-functional teams in

executing project deliverables.

KEY STRENGTHS AND PROFICIENCIES

Research & Development Stakeholder Relations Clinical Data Evaluation

Project Management Strategic Planning Thrombosis

Vendor Management Medical Writing Oncology and Supportive Care

Team Leadership/Training Literature Retrieval/Analysis Pain Management

Publications Management New Product Launch Neurological Disorders

PROFESSIONAL EXPERIENCE AND KEY ACCOMPLISHMENTS

Daiichi Sankyo, Inc. Parsippany, NJ 2014

Associate Director, Medical Research & Strategy

Plans, manages, and executes the global and regional Medical Communication Plan in support of factor

Xa inhibitor, Savaysa™, including but not limited to publications and medical slide

Oversee development of medical slide sets to assure alignment with strategic direction of brand and/or

therapeutic area and assure alignment with key stakeholders.

Manages and execution of the publication plan and provides timely and critical review of materials (e.g.,

manuscripts, abstracts, etc.)

Track and manage the budget and oversee external vendor/agency activities.

Spearheaded a new therapy area in a short amount of time and recruited /trained new publications

agency to support Savaysa while transitioning current projects away from previous vendor.

Teva Pharmaceuticals Frazer, PA 2012 2013

Associate Director, Global Scientific Affairs

Oversaw strategic publication planning and development, and monitors all publication-related activities

for compliance with company policy, for all supported products.

Collaborated with and lead the cross-functional matrix team to develop, plan, and refine publication

strategies and tactics in support of the G-CSF portfolio, Revascor, and pridopidine.

Drove the execution and delivery of high–quality, timely publications in support of the G-CSF

portfolio, Revascor, and pridopidine.

Liaised with key functions within Teva (Research and Development, Biostatistics, Global Medical

Affairs, and Commercial), external medical communications agencies, country affiliates, and external

authors.

Built and maintained excellent relationships with opinion leaders, investigators, journal editors, and

congress secretariats on strategic publication initiatives/activities.

Managed publication vendor and authors, ensuring that timelines, expectations, and budgets are within

the scope of the publication plan.

Managed and participated in competitive medical intelligence services at key medical meetings.

Successfully supported many therapy areas and products simultaneously, as well as arranged and led 3

successful publication advisory boards during tenure.

Shereen Abou-Gharbia – Page 2

PROFESSIONAL EXPERIENCE (CONTINUED)

Biogen Idec Weston, MA 2011 2012

Senior Manager, Global Medical Communications

Coordinated the development and execution of the Tecfidera (BG-12) strategic publication plan.

Liaised with key functions in Biogen Idec (Research and Development, Global Medical Affairs, and

commercial), external medical communications agencies, country affiliates, and external authors.

Managed publication vendor and authors, ensuring that timelines, expectations, and budgets are within

the scope of the publication plan.

Solely and successfully led the cross-functional global publications team consisting of 30+ members

across various regions of the world.

Developed a comprehensive, robust publications plan for a high-profile product under FDA review

(TECFIDERA) during the peri-launch period that consisted of 60+ publications.

Published 2 pivotal publications of 2 phase 3 studies in NEJM. Recipient of 5 Applause awards in

recognition of my dedication, hard work, and innovation.

Everyday Health, Inc. New York City, NY 2010 2011

Team Leader, Ask a Pharmacist

Supervised of all pharmacists and any product-related activities for the Ask a Pharmacist initiative and

PDRHealth.com.

Provided accurate/timely responses to medical queries from internal and external customers .

Responsible for latest scientific developments for medical conditions, therapies, label changes and

product recalls for dissemination to Everyday Health users.

Developed and maintained SOPs in compliance with Everyday Health and best practices.

Drafted, edited, and updated demand-driven newsletters, FAQs, and blogs geared towards promoting

consumer wellness and knowledge to play an active role in their health.

Successfully launched and developed and managed a new program ‘Ask a pharmacist’ for the company.

Led a group of 30+ pharmacist across the country via telecommunications (remotely).

Managed PDRHealth.com (new company bought by Everyday Health), a consumer wellness website

geared toward patients to aid in the understanding of medications and conditions.

Cephalon, Inc. Frazer, PA 2005 2009

Manager, Medical Communications

Publications Lead for cross-functional team responsible for seamless execution and implementation of

the strategic publications plan ensuring timely delivery of high quality, focused publications to target

audiences.

Led the development and execution of a strategic publications plan critical for successful product

launch of AMRIX® (cyclobenzaprine extended-release capsules).

Provided expertise and input to a wide variety of key medical/scientific concepts and projects in the

assigned therapeutic areas and skills groups.

Built and maintained excellent relationships with opinion leaders, investigators, journal editors, and

congress secretariats on strategic publication initiatives/activities.

Managed, motivated and effectively integrated external agencies for publications deliverables.

Key contributor to the successful launches of several products including VIVITROL, FENTORA and

AMRIX.

Medical Information Specialist

Led launch preparation for 2 key marketed products: VIVITROL® (naltrexone for extended-release

suspension) and FENTORA® (fentanyl buccal tablet).

Performed medical review of advertising and promotional materials for designated therapeutic areas .

Provided timely, accurate medical information to internal and external customers.

Developed and maintained repository of standard response documents and FAQs .

Mentored and trained members of professional services (e.g., medical information specialists/associates

and doctor of pharmacy candidates).

Shereen Abou-Gharbia – Page 3

PHARMACY EXPERIENCE

The Chester County Hospital West Chester, PA Pharmacist, Part-Time Dec. 2007 – Aug. 2010

Rite Aid Pharmacy Mercerville, NJ/Lionville, PA Pharmacy Intern/Pharmacist Sept. 2001 – Dec. 2005

EDUCATION & PROFESSIONAL DEVELOPMENT

University of the Sciences in Philadelphia, Doctorate of Pharmacy (Sept. 2001 – May 2005)

Cum Laude – Rho Chi National Honor Society

Rutgers University, B.A., Biological Sciences (Jan. 1998 – May 2001)

CREDENTIALS & TRAINING

Registered Pennsylvania Pharmacist (RPh) – RP440654

Authorization to Administer Injectables (PA) – RP1004185

Registered Florida Pharmacist (RPh) – PS49497

Registered Delaware Pharmacist (RPh) – A1-0004334

Registered New Jersey Pharmacist (RPh) – 28RI03536800

Advanced Cardiopulmonary Resuscitation (CPR) – First Aid

Drug Information Association (DIA) Medical Communications E-Learning Certificate Program

University of Oxford Continuing Professional Development Course–Getting Research Published: How

to Develop a Publication Strategy in Biomedicine

International Society for Medical Publication Professionals (ISMPP) Certified Medical Publication

Professional (CMPP)

PRESENTATIONS

Professional

G-CSF Publications Steering Committee Meeting; Chicago, IL; May 2013

G-CSF Data-Mining Meeting; Amsterdam, The Netherlands; May 2013

Pridopidine Clinical Advisory Board Meeting; Venice, Italy; April 2013

Teva Global Regional Brand Leadership Meeting; Malvern, PA; February 2013

G-CSF Launch Summit Team Meetings; Frazer, PA: 2012 to present

TECFIDERA® (BG-12) Advisory Committee Meeting; Madrid, Spain; April 2012

Global Medical Communications Monthly Meeting; Weston, MA; March 2012

TECFIDERA® (BG-12) Advisory Committee Meeting; WebEx; February 2012

ZENPEP® (DR pancrelipase) Launch Meeting; Orlando, FL; October 2009

AMRIX® Primary Care Publications Advisory Board Meeting; Philadelphia, PA; April 2009

AMRIX® Launch Summit Team Meetings; Frazer, PA: 2008 to 2009

Academic

Autism; Friends Hospital, Philadelphia, PA; April 2005

Abilify® (aripiprazole) for acute and chronic maintenance therapy in schizophrenia; Cooper Medical Center,

Camden, NJ; March 2005

Entecavir® is superior to lamivudine in reducing hepatitis B virus in patients with chronic hepatitis B infection; Horizon

NJ Health, West Trenton, NJ; March 2005

Eating Disorders; Wegman’s Market Pharmacy, Princeton, NJ; November 2004

Nosocomial Pneumonia; Virtua Memorial Hospital, Mount Holly, NJ; October 2004

Tikosyn® (dofetilide); St. Mary Medical Center, Langhorne, Pennsylvania; September 2004

Alcoholism; CVIM, West Chester, PA; August 2004

Diabetes-Type I and II; Covance Corporation, Radnor, PA; June 2004

Olanzapine-induced diabetes-is it a class effect? USP, Philadelphia, PA; November 2003

Shereen Abou-Gharbia – Page 4

AWARDS

Daiichi Sankyo

March 2014 SAVAYSA Publications Dedication and Teamwork; Arigato Recognition

Award

Teva Pharmaceuticals

February 2013 Initiative and Dedication; Encore Recognition

Biogen Idec

January 2012 TECFIDERA (BG-12) Publications Plan 2012-2013; Applause Award

May 2012 TECFIDERA Presentations at AAN 2012 Meeting; Applause Award

July 2012 Publications of DEFINE and CONFIRM in NEJM; Applause Award

July 2012 Publications of DEFINE and CONFIRM in NEJM Applause Award

August 2012 TECFIDERA Publications Lead; Applause Award

Contact this candidate